28 employees
BMG Pharma is a pharmaceuticals company and the first to develop patented biomaterials based on modified Sodium Hyaluronate.
2011
$2.4M
from 1 investors over 1 rounds
BMG Pharma raised $2.4M on April 29, 2021
Investors: FINANZIARIA REGIONALE FRIULI VENEZIA GIULIA - FRIULIA S.P.A.